CD274 and neoplasm: Three tumor cell populations with different percentages of MEL-526 expressing PD-L1 were used in the study: PD-L1low (without exogenous PD-L1, 2.45%), PD-L1int (intermediate, 50.9%), and PD-L1high (high, 100%) (Figure 1C).